Practice Patterns Among United States Cardiologists for Managing Adults With Atrial Fibrillation (from the AFFECTS Registry)

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1122-1129

  Reiffel, James A ^a   Kowey, Peter R ^b   Myerburg, Robert ^c   Naccarelli, Gerald V ^d   Packer, Douglas L ^e   Pratt, Craig M ^f   Reiter, Michael J ^g   Waldo, Albert L ^h  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e MAYO CLINIC   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; WARFARIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BRAIN HEMORRHAGE; CARDIOLOGIST; CARDIOTOXICITY; CONNECTIVE TISSUE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HEPATOBILIARY DISEASE; HUMAN; HYPERTENSION; INFECTION; INFESTATION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL PRACTICE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOLOGY; CLINICAL COMPETENCE; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 77950460086     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.11.046     Document Type: Article

References (12)

1. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H.J., Frye R.L., Halperin J.L., Kay G.N., Klein W.W., Levy S., McNamara R.L., Prystowsky E.N., Wann L.S., Wyse D.G., Gibbons R.J., Antman E.M., Alpert J.S., Faxon D.P., Fuster V., Gregoratos G., Hiratzka L.F., Jacobs A.K., Russell R.O., Smith S.C., Klein W.W., Alonso-Garcia A., Blomstrom-Lundqvist C., De Backer G., Flather M., Hradec J., Oto A., Parkhomenko A., Silber S., and Torbicki A. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38 (2001) 1231-1266
2. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Halperin J.L., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J.L., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
3. Hohnloser S.H., Kuck K.H., and Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 356 (2000) 1789-1794
4. Opolski G., Torbicki A., Kosior D.A., Szulc M., Wozakowska-Kaplon B., Kolodziej P., and Achremczyk P. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) study. Chest 126 (2004) 476-486
5. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., Said S.A., Darmanata J.I., Timmermans A.J., Tijssen J.G., and Crijns H.J. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
6. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., and Corley S.D. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
7. Corley S.D., Epstein A.E., DiMarco J.P., Domanski M.J., Geller N., Greene H.L., Josephson R.A., Kellen J.C., Klein R.C., Krahn A.D., Mickel M., Mitchell L.B., Nelson J.D., Rosenberg Y., Schron E., Shemanski L., Waldo A.L., and Wyse D.G. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 109 (2004) 1509-1513
8. Patton K., and Page R. Pharmacological therapy of atrial fibrillation. Expert Opin Invest Drugs 16 (2007) 169-179
9. Kowey P.R., Reiffel J.A., Myerburg R., Naccarelli G.V., Packer D.L., Pratt C.M., Reiter M.J., Waldo A.L., and AFFECTS Scientific Advisory Committee and Investigators. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS registry). Am J Cardiol 105 (2010) 1130-1134
10. Ogawa S., Yamashita T., Yamazaki T., Aizawa Y., Atarashi H., Inoue H., Ohe T., Ohtsu H., Okumura K., Katoh T., Kamakura S., Kumagai K., Kurachi Y., Kodama I., Koretsune Y., Saikawa T., Sakurai M., Sugi K., Tabuchi T., Nakaya H., Nakayama T., Hirai M., Fukatani M., and Mitamura H. Optimal treatment strategy for patients with paroxysmal atrial fibrillation. Circ J 73 (2009) 242-248
11. Curtis A.B., Seals A.A., Safford R.E., Slater W., Tullo N.G., Vidaillet H., Wilber D.J., and Slee A. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study. Am Heart J 149 (2005) 304-308
12. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., and Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375